StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) stock

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.92−0.09 (-8.88%)

Close on Nov 17, 2026Market cap $8.70MP/E –Yield –

Cellectar Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Cellectar Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$19.47M. For fiscal 2025 it was -$23.12M. The highest annual figure on record is -$3.38M in fiscal 2010.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$23.12M–
FY2024Dec 31, 2024-$47.58M–
FY2023Dec 31, 2023-$32.38M–
FY2022Dec 31, 2022-$25.22M–
FY2021Dec 31, 2021-$22.57M–
FY2020Dec 31, 2020-$13.93M–
FY2019Dec 31, 2019-$11.69M–
FY2018Dec 31, 2018-$11.44M–
FY2017Dec 31, 2017-$11.02M–
FY2016Dec 31, 2016-$8.28M–
FY2015Dec 31, 2015-$8.21M–
FY2014Dec 31, 2014-$8.84M–
FY2013Dec 31, 2013-$9.15M–
FY2012Dec 31, 2012-$6.59M–
FY2011Dec 31, 2011-$5.97M–
FY2010Dec 31, 2010-$3.38M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.01M–
Q1 FY2026Mar 31, 2026-$4.85M–
Q4 FY2025Dec 31, 2025-$4.34M–
Q3 FY2025Sep 30, 2025-$4.28M–
Q2 FY2025Jun 30, 2025-$5.12M–
Q1 FY2025Mar 31, 2025-$9.38M–
Q4 FY2024Dec 31, 2024-$10.91M–
Q3 FY2024Sep 30, 2024-$9.17M–
Q2 FY2024Jun 30, 2024-$14.14M–
Q1 FY2024Mar 31, 2024-$13.36M–
Q4 FY2023Dec 31, 2023-$9.60M–
Q3 FY2023Sep 30, 2023-$8.07M–
Q2 FY2023Jun 30, 2023-$7.53M–
Q1 FY2023Mar 31, 2023-$7.18M–
Q4 FY2022Dec 31, 2022-$7.41M–
Q3 FY2022Sep 30, 2022-$7.01M–
Q2 FY2022Jun 30, 2022-$5.76M–
Q1 FY2022Mar 31, 2022-$5.04M–
Q4 FY2021Dec 31, 2021-$4.51M–
Q3 FY2021Sep 30, 2021-$6.43M–
Q2 FY2021Jun 30, 2021-$6.88M–
Q1 FY2021Mar 31, 2021-$4.75M–
Q4 FY2020Dec 31, 2020-$3.87M–
Q3 FY2020Sep 30, 2020-$3.50M–
Q2 FY2020Jun 30, 2020-$3.05M–
Q1 FY2020Mar 31, 2020-$3.51M–
Q4 FY2019Dec 31, 2019-$2.68M–
Q3 FY2019Sep 30, 2019-$3.54M–
Q2 FY2019Jun 30, 2019-$2.65M–
Q1 FY2019Mar 31, 2019-$2.82M–
Q4 FY2018Dec 31, 2018-$2.74M–
Q3 FY2018Sep 30, 2018-$2.97M–
Q2 FY2018Jun 30, 2018-$2.55M–
Q1 FY2018Mar 31, 2018-$3.18M–
Q4 FY2017Dec 31, 2017-$2.83M–
Q3 FY2017Sep 30, 2017-$2.54M–
Q2 FY2017Jun 30, 2017-$2.66M–
Q1 FY2017Mar 31, 2017-$2.99M–
Q4 FY2016Dec 31, 2016-$2.35M–
Q3 FY2016Sep 30, 2016-$2.21M–

More Cellectar Biosciences figures

See a number that looks wrong?